We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial (427684)
ARTG ID 427684
ARTG Name
RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial
Product name
RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicines
Ingredients
rozanolixizumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information